Optimizing a Personalized Health Approach for Virtually Treating High-Risk Caregivers During COVID-19 and Beyond

优化个性化健康方法,以虚拟方式治疗 COVID-19 期间及之后的高风险护理人员

基本信息

  • 批准号:
    10709470
  • 负责人:
  • 金额:
    $ 97.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-23 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT With the spread of COVID-19, public health precautions have required physical distancing and a variety of shelter-in-place orders, causing rapid and substantial shifts in all aspects of family and community life. Data from COVID-19, supported by evidence from past national emergencies, suggest caregivers are at clear risk for secondary health effects because of the current pandemic. COVID-19 has been described as a “perfect vector for a mental health epidemic” due to the accumulated effects of pandemic-related fear, social isolation, post-traumatic stress, and mental health treatment barriers. These changes to daily life have been especially challenging for families of children with neurogenetic conditions (NGC), who experience high levels of baseline stress, are particularly vulnerable to reductions in targeted therapeutic services, and rely on medical and educational services that have been disrupted by COVID-19 related closures. Specifically, caregivers themselves are vulnerable to stress-related mental and physical health challenges because of the pandemic; they rarely receive treatment for their own mental health needs, and any treatments they do receive are typically disconnected from their child's care plan and are delivered by practitioners with little-to-no expertise in the needs of NGC families. These health care gaps are amplified among Black and other minority families. The proposed study will address the needs of caregivers of children with NGC by examining the feasibility, efficacy, and impact of a novel network for delivering personalized triage and digital treatment. Specifically, we propose to scale up and integrate a series of brief, evidence based digital health interventions to support caregiver mental health, parenting self-efficacy, and stress. Supervised graduate student trainees will implement rigorous, cost-effective, evidence-based interventions via telehealth. A key innovation of this work is that we will develop a personalized health routing algorithm that matches participants with relevant treatments using both clinical inputs and ecological momentary assessment (EMA) data, brief questionnaires “pinged” to caregiver phones via a smartphone app. A second innovation is that we will test the efficacy of peer-to-peer coaching in enhancing treatment uptake and outcomes. Coaching will be delivered by fellow NGC caregivers using an evidence-based motivational interviewing protocol. By the end of the award period, we will have generated a novel, scalable, and cost-effective solution for rapidly meeting acute needs for NGC caregivers through personalized, digital delivery of evidence-based treatments. This model can be rapidly scaled for other high-risk populations during COVID-19 (e.g. first responders, teachers, frontline workers) and future public health crises. Given substantial unmet needs existed among NGC families even prior to COVID- 19, this protocol has potential to fundamentally shift the status-quo for how treatment is selected and accessed in NGC caregivers and other underserved groups, including beyond the COVID-19 pandemic.
项目概要/摘要 随着 COVID-19 的传播,公共卫生预防措施需要保持身体距离并采取各种措施 就地避难令,导致家庭和社区生活的各个方面发生迅速而重大的变化。数据 来自 COVID-19 的数据以及过去国家紧急情况的证据表明,护理人员面临明显的风险 由于当前的大流行而造成的二次健康影响。 COVID-19 被描述为“完美的 由于与流行病相关的恐惧、社会孤立、 创伤后应激和心理健康治疗障碍。这些日常生活的变化尤其明显 对于患有神经遗传疾病 (NGC) 的儿童的家庭来说是一项挑战,他们的基线水平较高 压力大,特别容易受到针对性治疗服务减少的影响,并且依赖医疗和 因与 COVID-19 相关的关闭而中断的教育服务。具体而言,护理人员 由于大流行,他们自己很容易受到与压力有关的精神和身体健康挑战; 他们很少因自己的心理健康需求而接受治疗,而且他们接受的任何治疗都是 通常与孩子的护理计划无关,并且由缺乏专业知识的从业者提供 满足 NGC 家庭的需求。这些医疗保健差距在黑人和其他少数族裔家庭中被放大。 拟议的研究将通过检查可行性来满足 NGC 儿童照顾者的需求, 用于提供个性化分诊和数字治疗的新型网络的功效和影响。具体来说,我们 建议扩大和整合一系列简短的、基于证据的数字健康干预措施,以支持 照顾者的心理健康、育儿自我效能和压力。受监督的研究生实习生将 通过远程医疗实施严格、具有成本效益、循证的干预措施。本工作的一个关键创新点 我们将开发一种个性化的健康路由算法,将参与者与相关的人进行匹配 使用临床输入和生态瞬时评估 (EMA) 数据、简短调查问卷进行治疗 通过智能手机应用程序“ping”到护理人员的电话。第二个创新是我们将测试 同行辅导,以提高治疗的接受度和结果。辅导将由 NGC 同事提供 护理人员使用基于证据的动机访谈协议。在奖励期结束时,我们将 生成了一种新颖、可扩展且经济高效的解决方案,可快速满足 NGC 的迫切需求 通过个性化、数字化的循证治疗向护理人员提供帮助。该模型可以快速 在 COVID-19 期间针对其他高风险人群(例如急救人员、教师、一线工作人员)进行了扩展 未来的公共卫生危机。鉴于甚至在新冠疫情之前,NGC 家庭就存在大量未满足的需求, 19、该方案有可能从根本上改变治疗选择和获取方式的现状 NGC 护理人员和其他服务不足的群体,包括除 COVID-19 大流行之外的群体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bridgette Lynne Kelleher其他文献

Bridgette Lynne Kelleher的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bridgette Lynne Kelleher', 18)}}的其他基金

Optimizing a Personalized Health Approach for Virtually Treating High-Risk Caregivers During COVID-19 and Beyond
优化个性化健康方法,以虚拟方式治疗 COVID-19 期间及之后的高风险护理人员
  • 批准号:
    10363469
  • 财政年份:
    2022
  • 资助金额:
    $ 97.63万
  • 项目类别:
Validating a Scalable, Open Science Framework for Collecting Laboratory-Grade Data Remotely in Specialized Populations
验证可扩展的开放科学框架,用于在特殊人群中远程收集实验室级数据
  • 批准号:
    10289016
  • 财政年份:
    2021
  • 资助金额:
    $ 97.63万
  • 项目类别:
Telehealth Assessment of Syndromic Autism Risk in Infants
婴儿综合症自闭症风险的远程医疗评估
  • 批准号:
    10181077
  • 财政年份:
    2017
  • 资助金额:
    $ 97.63万
  • 项目类别:
Telehealth Assessment of Syndromic Autism Risk in Infants
婴儿综合症自闭症风险的远程医疗评估
  • 批准号:
    9386578
  • 财政年份:
    2017
  • 资助金额:
    $ 97.63万
  • 项目类别:
Predicting Autism through Behavioral and Biomarkers of Attention in Infants
通过婴儿注意力的行为和生物标志物预测自闭症
  • 批准号:
    8575340
  • 财政年份:
    2011
  • 资助金额:
    $ 97.63万
  • 项目类别:
Predicting Autism through Behavioral and Biomarkers of Attention in Infants
通过婴儿注意力的行为和生物标志物预测自闭症
  • 批准号:
    8254642
  • 财政年份:
    2011
  • 资助金额:
    $ 97.63万
  • 项目类别:
Predicting Autism through Behavioral and Biomarkers of Attention in Infants
通过婴儿注意力的行为和生物标志物预测自闭症
  • 批准号:
    8391338
  • 财政年份:
    2011
  • 资助金额:
    $ 97.63万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.63万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 97.63万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.63万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.63万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 97.63万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.63万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.63万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.63万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 97.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 97.63万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了